Kym White
Kym White

Kym White, who led Edelman’s health sector for over six years, joins Generate:Biomedicines, a drug generation company pioneering a machine learning-powered generative biology platform, as chief corporate affairs officer.

White most recently led communications for Verily, Alphabet Inc.'s research organization devoted to the study of life sciences, and also worked with Isomorphic Labs, another Alphabet unit that focuses on the use of AI in drug development.

She was previously SVP and chief communications officer at both CVS Health and Vertex Pharmaceuticals.

At Edelman, White managed client relationships, business and product development and the marketing of Edelman Health, as well as developing thought leadership.

In her new post, she will work to articulate the mission of Generate:Biomedicines and spearhead initiatives that raise the profile of the work being done in the field of generative biology.

“Kym brings a profound understanding of AI’s transformative power in biotech, paired with her expertise in corporate affairs, positioning us to amplify our influence and drive meaningful progress in the industry,” said Generate:Biomedicines CEO Mike Nally, who is also the CEO of Flagship Pioneering, the company’s founder.

Generate:Biomedicines has also promoted Lisa Wyman to chief technical operations officer.